menu

Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization

3 chapters
Play All
30 minutes
Chapter 1
ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    Less than 20% of patients admitted to the hospital with new-onset heart failure are assessed for coronary artery disease (CAD) even though revascularization can improve survival. Many transplant patients go without a CAD assessment or intervention at earlier stages, but treatment could slow progression of their heart failure or even reverse it. Join Drs. Adam DeVore, Lauren Barron, and Navin Kapur as they discuss the gaps in care with CAD and how you can take action to improve your patients’ outcomes.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Adam DeVore, MD
    Associate Professor of Medicine
    Duke University School of Medicine
    Durham, NC

    No disclosures reported.

    Faculty:
    Lauren Barron, MD
    Assistant Professor of Surgery
    Baylor College of Medicine
    Houston, TX

    No disclosures reported.

    Navin Kapur, MD
    Associate Professor
    Tufts University School of Medicine
    Boston, MA

    No disclosures reported.

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Howard Green has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
    • Mario Trucillo, PhD, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Recognize that patients with heart failure are often not assessed for coronary artery disease which can impact patient outcomes
    • Identify coronary artery disease and ischemia as drivers for worsening heart failure and the opportunity for revascularization to complement pharmacologic therapy to improve patient outcomes
    • Discuss revascularization data in high-risk percutaneous coronary intervention and cardiac surgery
    • Discuss the clinical impact of the heart team approach
  • Target Audience

    This activity is designed to meet the educational needs of cardiologists, nurse practitioners, physician assistants, and primary care physicians.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .5 AAPA Category 1 CME credits. Approval is valid until January 31, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity. 

  • Provider(s)/Educational Partner(s)

    Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.

  • Commercial Support

    This activity is supported by an independent educational grant from Abiomed, Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    Less than 20% of patients admitted to the hospital with new-onset heart failure are assessed for coronary artery disease (CAD) even though revascularization can improve survival. Many transplant patients go without a CAD assessment or intervention at earlier stages, but treatment could slow progression of their heart failure or even reverse it. Join Drs. Adam DeVore, Lauren Barron, and Navin Kapur as they discuss the gaps in care with CAD and how you can take action to improve your patients’ outcomes.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Adam DeVore, MD
    Associate Professor of Medicine
    Duke University School of Medicine
    Durham, NC

    No disclosures reported.

    Faculty:
    Lauren Barron, MD
    Assistant Professor of Surgery
    Baylor College of Medicine
    Houston, TX

    No disclosures reported.

    Navin Kapur, MD
    Associate Professor
    Tufts University School of Medicine
    Boston, MA

    No disclosures reported.

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Howard Green has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
    • Mario Trucillo, PhD, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Recognize that patients with heart failure are often not assessed for coronary artery disease which can impact patient outcomes
    • Identify coronary artery disease and ischemia as drivers for worsening heart failure and the opportunity for revascularization to complement pharmacologic therapy to improve patient outcomes
    • Discuss revascularization data in high-risk percutaneous coronary intervention and cardiac surgery
    • Discuss the clinical impact of the heart team approach
  • Target Audience

    This activity is designed to meet the educational needs of cardiologists, nurse practitioners, physician assistants, and primary care physicians.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .5 AAPA Category 1 CME credits. Approval is valid until January 31, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity. 

  • Provider(s)/Educational Partner(s)

    Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.

  • Commercial Support

    This activity is supported by an independent educational grant from Abiomed, Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

Facebook Comments

Schedule15 Apr 2024